Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome

Aim. To assess the long-term effectiveness and safety of moxonidine (Physiotens®), as antihypertensive treatment in patients with metabolic syndrome (MS), including women with menopausal MS. Material and methods. The study included 274 patients: 203 women (74 %) and 70 men (26 %). Postmenopausal wom...

Descripció completa

Dades bibliogràfiques

Autors principals:	E. V. Tishina, V. B. Mychka, Yu. V. Zhernakova, K. P. Ivanov, S. N. Tolstov, I. E. Chazova
Format:	Artigo
Idioma:	Russo
Publicat:	«SILICEA-POLIGRAF» LLC 2011-06-01
Col·lecció:	Кардиоваскулярная терапия и профилактика
Matèries:	metabolic syndrome arterial hypertension menopause moxonidine
Accés en línia:	https://cardiovascular.elpub.ru/jour/article/view/1805
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!